Robert R. Seltzer
Director
biopharmaceutical and drug development
Nephrogenex
Austria
Biography
Robert R. Seltzer has been on the Board of Directors since October 2013. Mr. Seltzer is a Managing Partner at Amzak Health, an investment firm focused on venture capital and growth equity opportunities in healthcare. Prior to joining Amzak Health in 2015, Mr. Seltzer was a Partner at Care Capital, a life sciences venture capital firm, where he spent over ten years investing in the healthcare sector. In that capacity, he served on the Board of Directors of a number of biopharmaceutical and drug development companies. Prior to his investing career, Mr. Seltzer was a management consultant at the Boston Consulting Group, and was previously Co-Founder and President of Trenza Corp.
Research Interest
Mr. Seltzer received his MBA from The Wharton School, a Masters in Biotechnology from the University of Pennsylvania, and a BS in Molecular Biophysics and Biochemistry from Yale University.
